Benign prostatic hyperplasia

Comfortable safe solution for the benign enlargement of the prostate

INTRODUCTION

Bening prostatic hyperplasia (BPH) is the most common benign tumor in men from age 50 and older. Life expectancy increases the incidence of BPH, which has become the major consultation in the urologist practice. It causes various symptoms such as occlusion of the lower urinary tract, pain and other.

Until recently, the main treatment for BPH was the transurethral resection of the prostate (known by the acronym TURP). This surgical procedure, the most common in urology, has been associated with postoperative complications, which have driven the search for other minimally invasive alternatives offering similar results, fewer side effects and a faster recovery for the patient as BPH laser vaporization with Multidiode™ SST200.

 

ilustraciones urología modificadas

PRODUCT

Multidiode™ SST200: all advantages

BPH treatment with Multidiode SST200 is a safe effective minimally invasive procedure that allows a faster recovery of patients, significantly reducing hospitalization.

Relief of symptoms is immediate, with the advantage of not causing side effects, such as impotence or urinary incontinence. Patients with clotting problems can also be treated, since there is no bleeding.

Multidiode SST200 platform is also indicated in the treatment of other conditions such as:

  • Benign urethral stricture
  • Bladder tumor
  • Condyloma Acuminatum
  • Urethral stricture
  • Lymph nodes
  • Carcinoma penile tumor resection
  • Carcinoma penile tumor resection
  • Nephrectomy 

GALLERY

Laser treatment of BPH

Laser treatment of BPH

Laser treatment of BPH